Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
Botulinum toxin A (BoNT-A) intravesical injections have been used to treat patients with refractory functional bladder disorders such as overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS), but the risk of adverse events and the need for repeated injections continue to...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2022-12-01
|
| Sarja: | Toxins |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2072-6651/14/12/838 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|